From Skeletal Development to the Creation of Pluripotent Stem Cell-derived Bone-forming Progenitors

Overview

Journal Philos Trans R Soc Lond B Biol Sci

Specialty Biology

Date 2018 May 23

PMID 29786553

Citations 8

Authors

Wai Long Tam

Frank P Luyten

Scott J Roberts

Affiliations

Soon will be listed here.

Abstract

Bone has many functions. It is responsible for protecting the underlying soft organs, it allows locomotion, houses the bone marrow and stores minerals such as calcium and phosphate. Upon damage, bone tissue can efficiently repair itself. However, healing is hampered if the defect exceeds a critical size and/or is in compromised conditions. The isolation or generation of bone-forming progenitors has applicability to skeletal repair and may be used in tissue engineering approaches. Traditionally, bone engineering uses osteochondrogenic stem cells, which are combined with scaffold materials and growth factors. Despite promising preclinical data, limited translation towards the clinic has been observed to date. There may be several reasons for this including the lack of robust cell populations with favourable proliferative and differentiation capacities. However, perhaps the most pertinent reason is the failure to produce an implant that can replicate the developmental programme that is observed during skeletal repair. Pluripotent stem cells (PSCs) can potentially offer a solution for bone tissue engineering by providing unlimited cell sources at various stages of differentiation. In this review, we summarize key embryonic signalling pathways in bone formation coupled with PSC differentiation strategies for the derivation of bone-forming progenitors.This article is part of the theme issue 'Designer human tissue: coming to a lab near you'.

Citing Articles

Efficient Production of Chondrocyte Particles from Human iPSC-Derived Chondroprogenitors Using a Plate-Based Cell Self-Aggregation Technique.

Hanaki S, Yamada D, Takao T, Iwai R, Takarada T Int J Mol Sci. 2024; 25(22).

PMID: 39596131 PMC: 11594242. DOI: 10.3390/ijms252212063.

A novel chondrocyte sheet fabrication using human-induced pluripotent stem cell-derived expandable limb-bud mesenchymal cells.

Takao T, Sato M, Fujisawa Y, Toyoda E, Yamada D, Hitsumoto Y Stem Cell Res Ther. 2023; 14(1):34.

PMID: 36829201 PMC: 9960196. DOI: 10.1186/s13287-023-03252-4.

Identification of Surface Antigens That Define Human Pluripotent Stem Cell-Derived PRRX1+Limb-Bud-like Mesenchymal Cells.

Yamada D, Takao T, Nakamura M, Kitano T, Nakata E, Takarada T Int J Mol Sci. 2022; 23(5).

PMID: 35269809 PMC: 8910499. DOI: 10.3390/ijms23052661.

Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects.

Tam W, Freitas Mendes L, Chen X, Lesage R, Van Hoven I, Leysen E Stem Cell Res Ther. 2021; 12(1):513.

PMID: 34563248 PMC: 8466996. DOI: 10.1186/s13287-021-02580-7.

Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies.

Wang Z, Maimaitiaili A, Wang T, Song X Infect Drug Resist. 2021; 14:1781-1794.

PMID: 34025123 PMC: 8132576. DOI: 10.2147/IDR.S304864.

References

Crane G, Jeffery E, Morrison S . Adult haematopoietic stem cell niches. Nat Rev Immunol. 2017; 17(9):573-590. DOI: 10.1038/nri.2017.53. View

Lefebvre V, Behringer R, de Crombrugghe B . L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage. 2001; 9 Suppl A:S69-75. DOI: 10.1053/joca.2001.0447. View

Umeda K, Oda H, Yan Q, Matthias N, Zhao J, Davis B . Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells. Stem Cell Reports. 2015; 4(4):712-26. PMC: 4400647. DOI: 10.1016/j.stemcr.2015.02.012. View

Lefebvre V, Dvir-Ginzberg M . SOX9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res. 2016; 58(1):2-14. PMC: 5287363. DOI: 10.1080/03008207.2016.1183667. View

Bruder S, Jaiswal N, Haynesworth S . Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997; 64(2):278-94. DOI: 10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f. View

Akiyama H, Kim J, Nakashima K, Balmes G, Iwai N, Deng J . Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A. 2005; 102(41):14665-70. PMC: 1239942. DOI: 10.1073/pnas.0504750102. View

Zelzer E, Glotzer D, Hartmann C, Thomas D, Fukai N, Soker S . Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev. 2001; 106(1-2):97-106. DOI: 10.1016/s0925-4773(01)00428-2. View

Zhang C, Cho K, Huang Y, Lyons J, Zhou X, Sinha K . Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci U S A. 2008; 105(19):6936-41. PMC: 2383965. DOI: 10.1073/pnas.0710831105. View

Barberi T, Willis L, Socci N, Studer L . Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2005; 2(6):e161. PMC: 1160574. DOI: 10.1371/journal.pmed.0020161. View

10.

Keller G . Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 2005; 19(10):1129-55. DOI: 10.1101/gad.1303605. View

11.

Yoon B, Ovchinnikov D, Yoshii I, Mishina Y, Behringer R, Lyons K . Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci U S A. 2005; 102(14):5062-7. PMC: 555995. DOI: 10.1073/pnas.0500031102. View

12.

Wilkin D, Szabo J, Cameron R, Henderson S, Bellus G, Mack M . Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998; 63(3):711-6. PMC: 1377389. DOI: 10.1086/302000. View

13.

Pan Q, Yu Y, Chen Q, Li C, Wu H, Wan Y . Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol. 2008; 217(1):228-41. DOI: 10.1002/jcp.21496. View

14.

Bi W, Deng J, Zhang Z, Behringer R, de Crombrugghe B . Sox9 is required for cartilage formation. Nat Genet. 1999; 22(1):85-9. DOI: 10.1038/8792. View

15.

Craft A, Rockel J, Nartiss Y, Kandel R, Alman B, Keller G . Generation of articular chondrocytes from human pluripotent stem cells. Nat Biotechnol. 2015; 33(6):638-45. DOI: 10.1038/nbt.3210. View

16.

Langer R, Vacanti J . Tissue engineering. Science. 1993; 260(5110):920-6. DOI: 10.1126/science.8493529. View

17.

Bourne S, Polak J, Hughes S, Buttery L . Osteogenic differentiation of mouse embryonic stem cells: differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting. Tissue Eng. 2004; 10(5-6):796-806. DOI: 10.1089/1076327041348293. View

18.

Zou Q, Wu M, Zhong L, Fan Z, Zhang B, Chen Q . Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture. PLoS One. 2016; 11(2):e0149023. PMC: 4755601. DOI: 10.1371/journal.pone.0149023. View

19.

Razzaque M . The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009; 5(11):611-9. PMC: 3107967. DOI: 10.1038/nrendo.2009.196. View

20.

Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi R . BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res. 2006; 21(4):637-46. PMC: 2435171. DOI: 10.1359/jbmr.060109. View